Caladrius Biosciences, Inc.
USD0.43
-0.09 (-16.75%)
CEO
David Mazzo
IPO Date
1995-11-03
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$0.65
Prev. Close
$0.51
Day Low
$0.38
Day High
Market Cap
$0.00B
Volume
26.95M
Caladrius Biosciences to Present at Noble Capital Markets Virtual Investor Forum during the 16th Annual World Stem Cell Summit
Caladrius Biosciences, Inc. (CLBS) CEO David Mazzo on Q1 2021 Results - Earnings Call Transcript
Caladrius Biosciences, Inc. (CLBS) Reports Q1 Loss, Lags Revenue Estimates
Caladrius Biosciences to Host First Quarter 2021 Financial Results Conference Call on Thursday, May 6, 2021 at 4:30 p.m. Eastern Time
Is the Options Market Predicting a Spike in Caladrius Biosciences (CLBS) Stock?
Caladrius Biosciences, Inc. (CLBS) Upgraded to Buy: What Does It Mean for the Stock?
Caladrius Biosciences to Present at the H.C. Wainwright Global Life Sciences Virtual Conference